Company news
Amoeba Sa (EURONEXT:ALMIB) news
Amoeba Sa news releases on 6ix. Latest, Oct 2, 2026: Amoéba veut associer ses actionnaires à sa dernière levée de fonds, avant la monétisation de sa…
Press releases & updates
Amoéba veut associer ses actionnaires à sa dernière levée de fonds, avant la monétisation de sa plateforme cosmétique, pour financer son démarrage commercial
October 1, 2026
Amoéba organise un webinaire le 7 octobre 2026 à 18h00 pour présenter son augmentation de capital ouverte à tous
October 1, 2026
Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch
October 1, 2026
Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency
September 24, 2026
Amoéba annonce le succès de la première partie de sa levée de fonds destinée à atteindre l'autonomie financière
September 24, 2026
Amoéba : Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency
September 25, 2026
Amoéba : Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency
September 24, 2026
Amoéba : Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset
September 24, 2026
Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides
July 23, 2026
Amoéba has received marketing authorization in France for its biofungicide AXPERA
July 1, 2026
Amoéba : Amoéba has received marketing authorization in France for its biofungicide AXPERA
June 30, 2026
Amoéba : Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew
June 8, 2026
2026/04/28 6:00PM - Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards
April 28, 2026
Amoeba : Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards
April 28, 2026
Amoéba : Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards
April 28, 2026
Amoéba : Amoéba and Koppert highlight the potential of AXPERA technology in Brazil for strategic crops
April 13, 2026
Amoéba : Amoéba announces the success of its capital increase and raises EUR 6.67 million
March 26, 2026
Amoeba : Amoéba strengthens its financial visibility to support its industrial and commercial expansion
March 25, 2026
Amoéba : Amoéba strengthens its financial visibility to support its industrial and commercial expansion
March 25, 2026
Amoeba : Amoéba announces the publication of its Universal Registration Document 2025
March 18, 2026
Amoéba : Amoéba announces the publication of its Universal Registration Document 2025
March 18, 2026
Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
March 12, 2026
2026/03/11 6:00PM - Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
March 11, 2026
Amoeba : Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
March 11, 2026
Amoéba : Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
March 11, 2026
Amoéba: final phase for marketing authorisation of AXPERA
February 24, 2026
Amoéba : Amoéba: final phase for marketing authorisation of AXPERA
February 23, 2026
2026/02/23 6:00PM - Amoéba: final phase for marketing authorisation of AXPERA
February 23, 2026
Amoéba : 2025 annual results: major regulatory and commercial advances paving the way for commercialisation in 2026
February 23, 2026
A natural breakthrough in protecting cereals and field crops
November 18, 2025
Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
October 29, 2025
Amoéba : Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
October 29, 2025